Next-Gen Congenital Heart Disease (CHD) : Market Forecast, Transformation, and Long-Term Trajectories
Discover trends, market shifts, and competitive outlooks for the congenital heart disease (chd) industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#What Are the Projected Market Size and Growth Rates for the Congenital Heart Disease (CHD) Market From 2025 To 2029?#_x000D_
The market for congenital heart disease (CHD) has seen a significant surge in recent years, escalating from a value of $4.42 billion in 2024 to an anticipated $4.87 billion in 2025, representative of a compound annual growth rate (CAGR) of 10.1%. The upward trend observed in the historic period can be linked to a rise in risk factors including obesity and smoking. Furthermore, the advancement in diagnostic tools, growth in the elderly population, widespread health awareness drives, better reimbursement policies, and enhanced funding for research and development have also contributed to this growth._x000D_
_x000D_
The market size of congenital heart disease (CHD) is predicted to witness robust expansion in the forthcoming years, reaching an estimated value of $7.05 billion in 2029 with a compound annual growth rate (CAGR) of 9.7%. The projected rise during this period is tied to increased availability of healthcare services in developing regions, consistent advancements in cardiac imaging methods, proactive awareness strategies emphasizing early detection and intervention, escalating global healthcare expenditures, and the advancement towards individualized medicine. Noteworthy trends during this forecast period encompass the utilization of minimally invasive surgical approaches, the growing application of telemedicine for remote patient surveillance and consultation, escalating requirements for tailor-made treatment methodologies, the creation of novel implantable apparatus with better performance and lifespan, and the incorporation of artificial intelligence and machine learning into diagnostic and therapeutic procedures._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=15545&type=smp_x000D_
_x000D_
#Which Major Market Drivers Are Expected to Boost the Growth Potential of the Congenital Heart Disease (CHD) Market?#_x000D_
The anticipated surge in cases of maternal diabetes is projected to boost the congenital heart disease (CHD) market in the coming years. Maternal diabetes, or gestational diabetes mellitus (GDM), is a form of diabetes that develops in women during pregnancy, who previously did not have the condition. The onset of maternal diabetes is triggered by changes in lifestyle patterns such as sedentary behavior and unhealthy eating habits, as well as a general increase in obesity rates among women of reproductive age. Maternal diabetes can trigger CHD in infants due to the impact of high blood sugar levels on fetal heart development. The high glucose levels in the mother’s blood can interfere with the normal development of the baby’s heart, thus enhancing the risk of CHD. For instance, the National Health Service, a UK-based government department, reported in October 2023 that negative pregnancy outcomes for women diagnosed with type 2 diabetes increased from 4.9% in 2021 to 6.6% in 2022. Consequently, the escalating cases of maternal diabetes are fueling CHD market growth._x000D_
_x000D_
#Which Key Market Segments Comprise the Congenital Heart Disease (CHD) Market and Drive Its Revenue Growth?#_x000D_
The congenital heart disease (CHD) market covered in this report is segmented –_x000D_
_x000D_
1) By Type: Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types_x000D_
2) By Diagnosis: Electrocardiogram, Chest X-ray, Echocardiogram, Transesophageal Echocardiogram, Pulse Oximetry, Exercise Stress Test, Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI), Cardiac Catheterization, Other Diagnosis_x000D_
3) By Treatment: Interventional Cardiology, Cardiac Surgery, Telemedicine, Medication Management, Lifestyle Modifications_x000D_
4) By Age Group: Infants, Children, Adolescents, Adults_x000D_
5) By Application: Hospitals And Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research And Academic Institutions_x000D_
_x000D_
Subsegments:_x000D_
1) By Heart Valve Defects: Aortic Valve Stenosis, Pulmonary Valve Stenosis, Mitral Valve Prolapse, Tricuspid Valve Defects, Valve Regurgitation_x000D_
2) By Heart Wall Defects: Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Atrioventricular Septal Defect (AVSD), Hypoplastic Left Heart Syndrome (HLHS), Tetralogy of Fallot (TOF)_x000D_
3) By Blood Vessel Defects: Coarctation Of The Aorta, Patent Ductus Arteriosus (PDA), Pulmonary Artery Stenosis, Transposition Of The Great Arteries (TGA), Truncus Arteriosus_x000D_
4) By Other Types: Single Ventricle Defects, Ebstein’s Anomaly, Total Anomalous Pulmonary Venous Return (TAPVR), Coronary Artery Anomalies, Pulmonary Venous Obstruction_x000D_
_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=15545&type=smp_x000D_
_x000D_
#Which Areas Are Leading Regions in the Congenital Heart Disease (CHD) Market Expansion Across the Globe?#_x000D_
North America was the largest region in the congenital heart disease (CHD) market in 2023. The regions covered in the congenital heart disease (CHD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#What Are the Key Market Trends in theCongenital Heart Disease (CHD) Market Over the Coming Years?#_x000D_
Leading firms in the congenital heart disease market are focusing on the creation of non-surgical heart valves to enhance patient outcomes and quality of life. Such heart valves, also known as transcatheter, are medical aids designed to address heart valve ailments without the need for traditional open-heart surgery. In a notable example from February 2023, Medtronic, an American medical technology firm, relaunched its Harmony Transcatheter Pulmonary Valve (TPV) System. This system, a revolutionary minimally invasive alternative to open-heart surgery, caters to patients with congenital heart disease specifically those who have native or surgically repaired right ventricular outflow tract (RVOT) anomalies. It’s first of its kind valve system approved by FDA and designed for the right side of heart. It is intended to offer a non-surgical remedy for patients dealing with severe pulmonary valve regurgitation. The much talked about Harmony TPV System got its nod from the U.S. FDA in 2021, and was later relaunched post a voluntary recall. This move signifies Medtronic’s dedication towards developing impactful solutions for congenital heart disease patients._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#How Is the Congenital Heart Disease (CHD) Market Conceptually Defined?#_x000D_
Congenital heart disease (CHD) refers to a range of birth defects affecting the structure and function of the heart that are present at birth. These defects can involve the walls of the heart, the valves of the heart, and the arteries and veins near the heart. The treatment for CHD depends on the type and severity of the defect and may include medications, catheter-based interventions, open-heart surgery, or heart transplantation._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15545_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 3156230293_x000D_
Asia +44 2071930708_x000D_
Europe +44 2071930708_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
